Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, Published Erratum, PLoS One called Corrigendum: MPX-004 and MPX-007: new pharmacological tools to study the physiology of NMDA receptors containing the GluN2A subunit [Erratum to document cited in CA168:122429], Author is The PLOS ONE Staff, which mentions a compound: 188781-36-4, SMILESS is O=C(C1=NC(C)=C(Cl)N=C1)O, Molecular C6H5ClN2O2, Reference of 5-Chloro-6-methylpyrazine-2-carboxylic acid.
There is an error in affiliation 1 for authors Robert A. Volkmann, Christopher M. Fanger, David R. Anderson, Frank S. Menniti. Affiliation 1 should be: Mnemosyne Pharmaceuticals, Inc. (now Luc Therapeutics) 400 Technol. Square, Cambridge, MA 02139, United States of America
The article 《Corrigendum: MPX-004 and MPX-007: new pharmacological tools to study the physiology of NMDA receptors containing the GluN2A subunit [Erratum to document cited in CA168:122429]》 also mentions many details about this compound(188781-36-4)Reference of 5-Chloro-6-methylpyrazine-2-carboxylic acid, you can pay attention to it, because details determine success or failure
Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics